Skip to main content

Human antibodies made in cows could be developed to treat MERS

Human antibodies made in genetically engineered cows have proved safe in an early stage clinical trial, US scientists said on Wednesday, and could be developed into a treatment for the fatal viral disease, MERS. MERS, or Middle East Respiratory Syndrome, is a SARS-like viral infection first identified in Saudi Arabia in 2012 that has caused deadly outbreaks in the Middle East as well as sporadic cases around the world. Despite more than five years of waves of infection, no effective treatment or vaccine has been developed against MERS, which has a 35 per cent case fatality rate and has so far killed at least 740 people worldwide.
More than 80 per cent of MERS cases have been reported in Saudi Arabia, according to the World Health Organization. In research published in the Lancet Infectious Diseases journal on Wednesday, scientists found that human antibodies called SAB-301 generated in so-called transchromosomic cattle — animals with human DNA incorporated into their genome — were safe in healthy volunteers.
The antibodies also persisted for more time than the MERS virus typically remains in the body, the study found, with antibodies still detected in bloodstream after 90 days. This points a way ahead for the antibodies — which offer immunity against an invading infection — to be tested in further trials in people infected with MERS, the researchers said.
“This is the first study to show the safety and immune effects of a potential treatment for MERS,” said John Beigel at Leidos Biomedical Research, who co-led the U.S. government-funded study. “The data from our study suggest that SAB-301 is safe, and further research into the treatment is warranted.” The idea of using human antibodies has developed in recent years in a variety of severe and emerging diseases, including flu, severe acute respiratory syndrome (SARS), MERS and Ebola.
Blood plasma harvested from people whose immune systems have successfully fought the disease contains the right antibodies and can be given to other patients to help their immune systems fight the virus. But harvesting human plasma is not always easy or swift when a new disease emerges, so scientists turned to the idea of transchromosomic cattle as a way of manufacturing specific antibodies in larger amounts. Transchromosomic cattle have human DNA that codes for human antibodies incorporated into their genome.
To make SAB-301, they were injected with a part of the MERS virus, stimulating their immune systems to produce antibodies against it. The antibodies were then extracted from the cattle’s blood and purified. “The process of creating antibody treatments by harvesting antibodies from human donors is slow and often small-scale,” said Beigel. “However, the cattle-produced antibodies could be created as soon as three months.”

Comments

Post a Comment

Popular posts from this blog

As many as 12 killed in New York’s deadliest fire in decades

More than 160 firefighters helped bring the blaze under control. (Source: Fire Department New York/Twitter) A massive fire ignited accidentally by a three-year-old boy swept through a five-story apartment building in New York, killing at least 12 people including a toddler and injuring four others in the deadliest blaze to hit the city in decades. The fire broke out around 6:50 pm (local time) yesterday on the first floor of the Prospect Avenue apartment in the Bronx borough of the city and spread quickly, officials said, adding that the cause of the blaze is under investigation. “We found that this fire started in a kitchen on the first floor,” fire commissioner Daniel Nigro said. “It started from a young boy, three and a half years old, playing with the burners on the stove. The fire got started, the mother was not aware of it – she was alerted by the young man screaming.” The boy’s mother fled with her two children, leaving the door to the apartment open – allowing t...
Post a Comment
Read more

Ukraine crisis: Exchange of hundreds of prisoners takes place

Ukrainian President Petro Poroshenko attends a ceremony to welcome prisoners of war (POWs), released after the exchange with pro-Russian separatists, upon their arrival at an airport in Kharkiv, Ukraine December 27, 2017. (Source: Reuters)  Ukraine and separatist rebels in the east of the country have exchanged hundreds of prisoners, in one of the biggest swaps since the conflict began in 2014. Around 230 people were sent to rebel-held areas in return for 74 prisoners who had been held by pro-Russia rebels in the Donetsk and Luhansk regions, BBC reported on Wednesday. It was the first swap in 15 months. The release and exchange of prisoners was one of the points in the Minsk peace agreement, signed in 2015. The deal has stalled since and analysts say the swap does not signify wider progress. Both sides continue to hold other prisoners. The number of prisoners swapped was lower than initially announced after dozens of people who were meant to be returned to rebel-held terr...
Post a Comment
Read more

Nepal declares ban on solo, blind and double amputee climbers from Everest

This ban is likely to irk solo mountaineers, who enjoy the challenge of climbing alone. In a bid to prevent accidents, Nepal has banned solo climbers from climbing its mountains, including Mount Everest, reported news agency AFP. Earlier on Friday, the cabinet declared revised regulations of the Himalayan nation’s mountaineering, where banning solo climbers from scaling its mountains was one of the key measures being flagged ahead of the 2018 spring climbing season. The cabinet also declared a ban on double amputee and blind climbers, even though Everest has drawn multitudes of mountaineers wanting to overcome their disabilities and achieve the formidable feat. “The changes have barred solo expeditions, which were allowed before,” Maheshwor Neupane, secretary at the Ministry of Culture, Tourism and Civil Aviation, told AFP. Neupane added that the law was revised to make mountaineering safer and decrease deaths. Earlier in April this year, an experienced...
Post a Comment
Read more